FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065146661> ?p ?o ?g. }

• W2065146661 endingPage "211" @default.
• W2065146661 startingPage "204" @default.
• W2065146661 abstract "<b><i>Background:</i></b> There is growing evidence that chemokines are potentially important mediators of the pathogenesis of atherosclerotic disease. Major atherothrombotic complications, such as stroke and myocardial infarction, are common among atrial fibrillation (AF) patients. This increase in risk of adverse events may be predicted by a score based on the presence of certain clinical features of chronic heart failure, hypertension, age 75 years or greater, diabetes and stroke (the CHADS₂ score). Our objective was to assess the prognostic value of plasma chemokines CCL2, CXCL4 and CX₃CL1, and their relationship with the CHADS₂ score, in AF patients. <b><i>Methods:</i></b> Plasma CCL2, CXCL4 and CX₃CL1 were measured in 441 patients (59% male, mean age 75 years, 12% paroxysmal, 99% on warfarin) with AF. Baseline clinical and demographic factors were used to define each subject's CHADS₂ score. Patients were followed up for a mean 2.1 years, and major adverse cardiovascular and cerebrovascular events (MACCE) were sought, being the combination of cardiovascular death, acute coronary events, stroke and systemic embolism. <b><i>Results:</i></b> Fifty-five of the AF patients suffered a MACCE (6% per year). Those in the lowest CX₃CL1 quartile (≤0.24 ng/ml) had fewest MACCE (p = 0.02). In the Cox regression analysis, CX₃CL1 levels >0.24 ng/ml (Hazard ratio 2.8, 95% CI 1.02-8.2, p = 0.045) and age (p = 0.042) were independently linked with adverse outcomes. The CX₃CL1 levels rose directly with the CHADS₂ risk score (p = 0.009). The addition of CX₃CL1 did not significantly increased the discriminatory ability of the CHADS₂ clinical factor-based risk stratification (c-index 0.60 for CHADS₂ alone versus 0.67 for CHADS₂ plus CX₃CL1 >0.24 ng/ml, p = 0.1). Aspirin use was associated with lower levels of CX₃CL1 (p = 0.0002) and diabetes with higher levels (p = 0.031). There was no association between CXCL4 and CCL2 plasma levels and outcomes. <b><i>Conclusion:</i></b> There is an independent association between low plasma CX₃CL1 levels and low risk of major cardiovascular events in AF patients, as well as a linear association between CX₃CL1 plasma levels and CHADS₂-defined cardiovascular risk. The potential for CX₃CL1 in refining risk stratification in AF patients merits consideration." @default.
• W2065146661 created "2016-06-24" @default.
• W2065146661 creator A5001907415 @default.
• W2065146661 creator A5019359947 @default.
• W2065146661 creator A5038405190 @default.
• W2065146661 creator A5076002640 @default.
• W2065146661 date "2014-01-01" @default.
• W2065146661 modified "2023-10-18" @default.
• W2065146661 title "Plasma CX₃CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project" @default.
• W2065146661 cites W112392588 @default.
• W2065146661 cites W1964999412 @default.
• W2065146661 cites W1971347950 @default.
• W2065146661 cites W1975084506 @default.
• W2065146661 cites W1982982006 @default.
• W2065146661 cites W1983738772 @default.
• W2065146661 cites W1984115097 @default.
• W2065146661 cites W1986588452 @default.
• W2065146661 cites W1996140994 @default.
• W2065146661 cites W2003043379 @default.
• W2065146661 cites W2010052806 @default.
• W2065146661 cites W2019782074 @default.
• W2065146661 cites W2021189846 @default.
• W2065146661 cites W2023143117 @default.
• W2065146661 cites W2023438827 @default.
• W2065146661 cites W2042835074 @default.
• W2065146661 cites W2056400192 @default.
• W2065146661 cites W2058054323 @default.
• W2065146661 cites W2061812498 @default.
• W2065146661 cites W2062786076 @default.
• W2065146661 cites W2063061428 @default.
• W2065146661 cites W2071306907 @default.
• W2065146661 cites W2079592184 @default.
• W2065146661 cites W2080281055 @default.
• W2065146661 cites W2100293635 @default.
• W2065146661 cites W2113021651 @default.
• W2065146661 cites W2117408086 @default.
• W2065146661 cites W2138983873 @default.
• W2065146661 cites W2142116686 @default.
• W2065146661 cites W2145110767 @default.
• W2065146661 cites W2147797899 @default.
• W2065146661 cites W2150576478 @default.
• W2065146661 cites W2165588599 @default.
• W2065146661 cites W2170813218 @default.
• W2065146661 cites W2328176404 @default.
• W2065146661 cites W4211201645 @default.
• W2065146661 doi "https://doi.org/10.1159/000365841" @default.
• W2065146661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25301077" @default.
• W2065146661 hasPublicationYear "2014" @default.
• W2065146661 type Work @default.
• W2065146661 sameAs 2065146661 @default.
• W2065146661 citedByCount "11" @default.
• W2065146661 countsByYear W20651466612015 @default.
• W2065146661 countsByYear W20651466612016 @default.
• W2065146661 countsByYear W20651466612017 @default.
• W2065146661 countsByYear W20651466612019 @default.
• W2065146661 countsByYear W20651466612021 @default.
• W2065146661 countsByYear W20651466612022 @default.
• W2065146661 crossrefType "journal-article" @default.
• W2065146661 hasAuthorship W2065146661A5001907415 @default.
• W2065146661 hasAuthorship W2065146661A5019359947 @default.
• W2065146661 hasAuthorship W2065146661A5038405190 @default.
• W2065146661 hasAuthorship W2065146661A5076002640 @default.
• W2065146661 hasConcept C126322002 @default.
• W2065146661 hasConcept C127413603 @default.
• W2065146661 hasConcept C164705383 @default.
• W2065146661 hasConcept C2778198053 @default.
• W2065146661 hasConcept C2779161974 @default.
• W2065146661 hasConcept C2780645631 @default.
• W2065146661 hasConcept C500558357 @default.
• W2065146661 hasConcept C71924100 @default.
• W2065146661 hasConcept C78519656 @default.
• W2065146661 hasConceptScore W2065146661C126322002 @default.
• W2065146661 hasConceptScore W2065146661C127413603 @default.
• W2065146661 hasConceptScore W2065146661C164705383 @default.
• W2065146661 hasConceptScore W2065146661C2778198053 @default.
• W2065146661 hasConceptScore W2065146661C2779161974 @default.
• W2065146661 hasConceptScore W2065146661C2780645631 @default.
• W2065146661 hasConceptScore W2065146661C500558357 @default.
• W2065146661 hasConceptScore W2065146661C71924100 @default.
• W2065146661 hasConceptScore W2065146661C78519656 @default.
• W2065146661 hasIssue "3" @default.
• W2065146661 hasLocation W20651466611 @default.
• W2065146661 hasLocation W20651466612 @default.
• W2065146661 hasOpenAccess W2065146661 @default.
• W2065146661 hasPrimaryLocation W20651466611 @default.
• W2065146661 hasRelatedWork W1864361583 @default.
• W2065146661 hasRelatedWork W1967841144 @default.
• W2065146661 hasRelatedWork W2018480046 @default.
• W2065146661 hasRelatedWork W2067977631 @default.
• W2065146661 hasRelatedWork W2300086221 @default.
• W2065146661 hasRelatedWork W2319489406 @default.
• W2065146661 hasRelatedWork W2335083084 @default.
• W2065146661 hasRelatedWork W2367140913 @default.
• W2065146661 hasRelatedWork W2763816051 @default.
• W2065146661 hasRelatedWork W3029306217 @default.
• W2065146661 hasVolume "38" @default.
• W2065146661 isParatext "false" @default.
• W2065146661 isRetracted "false" @default.

• next